Always Cutting-Edge
Working in partnership with Boehringer Ingelheim provides access to a state-of-the-art biopharmaceutical environment. Specific franchise technologies for either microbial or mammalian processes have been established and are very competitive assets of Boehringer Ingelheim's biopharmaceutical business. Continuous process improvements within these technologies do ensure low Cost of Goods in safe, reliable and robust processes operated on a science based approach.
